Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 8, 2003, Pages 809-812

  Kuschel, B ^a,b   Auranen, A ^a   Gregory, C S ^c   Day, N E ^a   Easton, D F ^a   Ponder, B A J ^a   Dunning, A M ^a   Pharoah, Paul D P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; GENE PRODUCT; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA REPAIR; FAMILIAL CANCER; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM;

BREAST NEOPLASMS; FEMALE; HUMANS; POLYMORPHISM, GENETIC; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS;

EID: 0041525297     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 in a population based series of breast cancer cases. Br. J. Cancer, 83: 1301-1308, 2000.
2. Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., and Stratton, M. R. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J. Natl. Cancer Inst. (Bethesda), 91: 943-949, 1999.
3. Antoniou, A. C., Pharoah, P. D. P., McMullen, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. A. J., and Easton, D. F. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br. J. Cancer, 86: 76-83, 2002.
4. Scully, R. Association of BRCA1 with RAD51 in mitotic and meiotic cells. Cell, 8: 265-275, 1997.
5. Matsuoka, S., Huang, M., and Elledge, S. J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science (Wash. DC), 282: 1893-1897, 1998.
6. Meijers-Heijboer, H., van den Ouweland, A., Klijn, J., Wasielewski, M., de Snoo, A., Oldenburg, R., Hollestelle, A., Houben, M., Crepin, E., van Veghel-Plandsoen, M., Elstrodt, F., van Duijn, C., Bartels, C., Meijers, C., Schutte, M., McGuffog, L., Thompson, D., Easton, D., Sodha, N., Seal, S., Barfoot, R., Mangion, J., Chang-Claude, J., Eccles, D., Eeles, R., Evans, D. G., Houlston, R., Murday, V., Narod, S., Peretz, T., Peto, J., Phelan, C., Zhang, H. X., Szabo, C., Devilee, P., Goldgar, D., Futreal, P. A., Nathanson, K. L., Weber, B., Rahman, N., and Stratton, M. R. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet., 31: 55-59, 2002.
7. Pharoah, P. D. P., Lipscombe, J. M., Redman, K., Easton, D. F., Ponder, B. A. J., and Day, N. E. Familial predisposition to breast cancer in a British population: implications for prevention. Eur. J. Cancer, 36: 773-779, 2000.
8. Day, N., Oakes, S., Luben, R., Khaw, K. T., Bingham, S., Welch, A., and Wareham, N. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br. J. Cancer, 80 (Suppl. 1): 95-103, 1999.
9. Easton, D. F., Peto, J., and Babiker, A. G. A. G. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat. Med., 10: 1025-1035, 1991.
10. Xie, X., and Ott, J. Testing linkage disequilibrium between a disease gene and marker loci. Am. J. Hum Genet. 53 (Suppl): 1107, 1993.
11. Goode, E. L., Dunning, A. M., Healey, C. S., Kuschel, B., Durocher, F., Teare, M. D., Pharoah, P. D. P., Ponder, B. A. J., Day, N. E., and Easton, D. F. Assessment of population stratification in a large population-based cohort. 10th Annual Meeting of the International Genetic Epidemiology Society. Garmisch Patenkirchen, Germany, 2001.
12. Goode E. L., Dunning A. M. Kuschel, B. Healey C. S., Day, N. E., Ponder, B. A. J., Easton, D. F., and Pharoah, P. D. P. Effect of germline genetic variation on breast cancer survival in a population-based study. Cancer Res., 62: 3052-3057, 2002.